康惠股份 (603139)
Shaanxi Kanghui Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data available
Company NameShaanxi Kanghui Pharmaceutical Co., Ltd.
Listing Date2017-04-21
Issue Price14.57RMB
Registered Capital998810k RMB
Legal RepresentativeLi Hongming
Registered AddressCaihong Second Road, High-Tech Industrial Development Zone, Qindu District, Xianyang City, Shaanxi Province
IndustryTraditional Chinese Medicine II
Main BusinessResearch, development, production, and sales of Chinese patent medicines
Company ProfileShaanxi Kanghui Pharmaceutical Co., Ltd. is a high-tech pharmaceutical enterprise integrating drug research, development, production, and sales. Currently, it operates three large-scale production bases and is a modern pharmaceutical company with over 110 product varieties covering internal medicine, surgery, orthopedics, gynecology, and other fields. The company possesses 5 exclusive national varieties, 10 national invention patents, and more than 20 varieties listed in the National Reimbursement Drug List. Several of its leading products have been designated as National Protected Traditional Chinese Medicines and National Key New Products, laying a solid market foundation for the company's development.
Stock Details
1. Key Indicators
- Total Shares(W): 9988.00
- Circulating A-Shares(W): 9988.00
- Earnings Per Share(RMB): -1.3300
- Net Assets Per Share(RMB): 7.2571
- Operating Revenue(W RMB): 35614.13
- Total Profit(W RMB): -15399.24
- **Net Profit Attributable to Parent(W RMB) **: -13250.39
- Net Profit Growth Rate(%): -246.07
- Weighted Return on Equity(%): -15.7600
- Operating Cash Flow Per Share(RMB): -0.0930
- Undistributed Profit Per Share(RMB): 1.4543
- Capital Reserve Per Share(RMB): 4.1251
2. Main Business
The main business covers:
- Research, development, production and sales of Chinese patent medicines
3. Company Basic Information
- Company Name: Shaanxi Kanghui Pharmaceutical Co., Ltd.
- Listing Date: 2017-04-21
- Industry: Pharmaceutical Manufacturing
- Address: Caihong Second Road, High-tech Industrial Development Zone, Qindu District, Xianyang City, Shaanxi Province
- Website: https://www.sxkh.com/
- Company Profile: On December 11, 2009, Shaanxi Kanghui Pharmaceutical Co., Ltd. and natural person Wang Yanling signed the "Sponsor Agreement", agreeing to establish a joint stock company by way of sponsorship. The registered capital of the company at the time of establishment was RMB 50 million. The sponsor, Shaanxi Kanghui Pharmaceutical Co., Ltd., subscribed to a capital contribution of RMB 43.35 million, with an actual paid-in capital of RMB 3.35 million. The remaining subscribed capital was fully paid before June 30, 2010. On December 11, 2009, Shaanxi Kanghui Pharmaceutical Co., Ltd. held its founding meeting and first shareholders' meeting, reviewing and approving the proposal for the company's establishment. On December 16, 2009, Shanghai Shanghui Certified Public Accountants Co., Ltd. issued the Shang Hui Shi Bao Zi (2009) No. 1908 "Capital Verification Report", verifying the initial capital contribution at the time of the company's establishment. On December 24, 2009, the company completed the industrial and commercial establishment registration procedures with the Shaanxi Provincial Administration for Industry and Commerce and obtained the Business License with registration number 610000100257840.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Jiaxing Yuehe Zhichuang Technology Partnership (Limited Partnership) | Corporate Entity | 2197.36 | 22.00 |
| 2 | Shaanxi Kanghui Holding Co., Ltd. | Corporate Entity | 1473.26 | 14.75 |
| 3 | Shanghai Chuangxiangying Enterprise Management Partnership (Limited Partnership) | Corporate Entity | 599.28 | 6.00 |
| 4 | TBP Traditional Medicine Investment Holdings (H.K.) Limited | Corporate Entity | 316.93 | 3.17 |
| 5 | Shanghai Sailexian Enterprise Management Consulting Co., Ltd. | Corporate Entity | 299.64 | 3.00 |
5. Concept Sectors
- Childcare Concept
- Rural Revitalization
- Medical Aesthetics Concept
- NMN Concept
- Helicobacter Pylori Concept
- Hepatitis Concept
- Synthetic Biology
- Micro-cap Stocks
- Consecutive Losses
- Equity Transfer
- Control Change
Remarks
- Data update date: 2025-09-30
- Data source: Public market information